Publications

Higher taxes on the wealthy and the productive don't deliver, and in fact lead to capital and talent flight, as France is about to find out.

It's time to focus on one of the U.S.'s trade success stories: agriculture, and specifically genetically modified (GM) seeds.

Californians flee in ever-larger numbers to low-tax states like Texas.

It should NOT surprise us that innovative companies find ways to solve the problems created by our tax code.

There are precious few federal agencies that are able to respond to issues and challenges as fast as they should. Fortunately, there’s one that is.

A gene trait in the first of the biotech seeds, Roundup Ready, goes off patent in 2014, and many more will soon follow. The industry has been developing a private sector process to govern the transition from patented to generic traits that relies on negotiations and contracts. Such a process would avoid the costly, litigious and adversarial approach Congress imposed on the pharmaceutical industry.

On January 1, 2013, a dizzying array of tax cuts, deductions and exemptions are scheduled to expire. Estimates of the impact on a typical working class family range from between $1,750 and $3,800 in additional taxes next year alone.